AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Immunotherapeutics companies announce plans to merge.
2003 MAR 12 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN), and Anosys, Inc., announced that they have preliminarily agreed to merge their operations to create a combined company focused on the field of immunotherapeutics and products for the treatment of cancer and infectious diseases.
The all-stock transaction is subject to the parties entering into a definitive merger agreement, approval by the shareholders of both companies, obtaining commitments for capital resources to fund the combined company's operations and various other conditions that must be satisfied prior to closing the merger. Epimmune also announced that it had withdrawn its S-1 registration statement for the sale of 7,250,000 shares of its common stock which had been previously filed on October 24, 2002 and amended on November 6, 2002.
"By combining our epitope technology with Anosys' exosome delivery technology we will create a company with significant expertise and broad intellectual property around activating antigen-specific immune responses, especially in the area of cancer vaccines," said Emile Loria, president and CEO of Epimmune.
"The combined company will have an expanded ...
- Epimmune and Anosys Announce Definitive Merger Agreement.
- Press release article from: PR Newswire May 12, 2003 700+ words
...privately-held Anosys in a strategic...will create a combined company focused on the...65% of the combined company and Anosys' existing stockholders...based on the Anosys balance sheet...million. The combined company will be headquartered...
- Epimmune and Anosys Announce Plans to Merge.
- Press release article from: PR Newswire February 13, 2003 700+ words
...Epimmune Inc. , and Anosys, Inc. today announced...operations to create a combined company focused on the...technology with Anosys' exosome delivery...Epimmune. "The combined company will have an expanded...programs. The combined company will also have...between ...
- Epimmune Enters Agreement For $13.5M Stock Merger With Anosys.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...longer, as Epimmune granted to Anosys a nonexclusive license to certain...shares in exchange for all of Anosys' common and preferred stock...would control 65 percent of the combined company and Anosys' shareholders would own no more...
- EPIMMUNE, ANOSYS NIXED MERGER CAUSED BY UNSATISFIED CONDITIONS.
- Magazine article from: BIOWORLD Today Lorenzo, Aaron August 14, 2003 700+ words
...there at the end." Anosys co-founder Jean...the concept of the combined company." But Loria said...all of privately held Anosys' common and preferred...controlled 65 percent of the combined company while shareholders...Park, Calif.-based Anosys would have owned no...
- Epimmune, Anosys Nixed Merger Caused By Unsatisfied Conditions.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...there at the end." Anosys co-founder Jean...the concept of the combined company." But Loria said...all of privately held Anosys' common and preferred...controlled 65 percent of the combined company while shareholders...Park, Calif.-based Anosys would have owned no...
- EPIMMUNE PLANS ACQUISITION OF ANOSYS FOR SYNERGISTIC PLATFORM.
- Magazine article from: BIOWORLD Today Lorenzo, Aaron February 14, 2003 700+ words
...that time." Now the combined company will work as one on...development, including Anosys' most advanced programs...France and Menlo Park. Anosys, founded as AP Cells...decisions regarding Anosys' personnel have not...resources to fund the combined company's operations and...
- Epimmune will stay in S.D. after merger. (Biotech).(Anosys)
- Magazine article from: San Diego Business Journal Webb, Marion February 24, 2003 700+ words
...certain cancer antigens to Anosys for use in its cancer therapy...in ex vivo cancer therapy. Anosys received Food and Drug Administration...investors in Epimmune and Anosys include Aventis, BankInvest...capital resources to fund the combined company's operations, and other...
- Epimmune and Anosys of the USA plan merger.
- Newspaper article from: Pharma Marketletter February 24, 2003 700+ words
...US firms Epimmune and Anosys say they have reached...operations to create a combined company focused on the field...epitope technology with Anosys' exosome delivery technology...cancer vaccines." The combined company, Dr Loria added...
Source: HighBeam Research, Immunotherapeutics companies announce plans to merge.